Literature DB >> 659873

Studies on the terminal stages of immune hemolysis. III. Distinction between the insertion of C9 and the formation of a transmembrane channel.

M D Boyle, J J Langone, T Borsos.   

Abstract

The intermediate product EAC1-8 released cytoplasmic components as a result of at least two sequential reactions after its interaction with C9. Binding of C9 to EAC1-8 occurred in a few minutes even at 0 degrees C. Trypsinization of EAC1-9 prepared and held at low temperature resulted in nullification of the potential hemolysis of these cells. A brief incubation at 30 or 37 degrees resulted in the formation of an intermediate whose hemolytic potential could not be nullified by trypsin. The failure of trypsin to nullify hemolysis was attributed to the insertion of C9 into the cell membrane. Studies on the effec of EDTA or low temperature suggested that the reported temperature-dependent step in E* formation described by Frank et al. was the insertion of C9. The results of the studies with 86Rb-labeled EAC1-8 indicated that a transmembrane channel was not formed until after the C9 had been inserted and a further reaction or reactions had occurred.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 659873

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Complement pore genesis observed in erythrocyte membranes by fluorescence microscopic single-channel recording.

Authors:  H Sauer; L Pratsch; G Fritzsch; S Bhakdi; R Peters
Journal:  Biochem J       Date:  1991-06-01       Impact factor: 3.857

2.  Steady-state analysis of tracer exchange across the C5b-9 complement lesion in a biological membrane.

Authors:  P J Sims; P K Lauf
Journal:  Proc Natl Acad Sci U S A       Date:  1978-11       Impact factor: 11.205

3.  Affinity of the C9 molecule for the C5b-8 complex compared with that for the complex containing C9 molecules.

Authors:  S L MacKay; J R Dankert
Journal:  Infect Immun       Date:  1994-07       Impact factor: 3.441

Review 4.  Is the membrane attack complex of complement an enzyme?

Authors:  M D Boyle
Journal:  Mol Cell Biochem       Date:  1984       Impact factor: 3.396

5.  Homologous species restriction in lysis of erythrocytes by terminal complement proteins.

Authors:  G M Hänsch; C H Hammer; P Vanguri; M L Shin
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

6.  Proteolytic modification of human complement protein C9: loss of poly(C9) and circular lesion formation without impairment of function.

Authors:  J R Dankert; A F Esser
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

7.  Inhibition of the lytic action of cell-bound terminal complement components by human high density lipoproteins and apoproteins.

Authors:  S I Rosenfeld; C H Packman; J P Leddy
Journal:  J Clin Invest       Date:  1983-04       Impact factor: 14.808

8.  Topological mapping of complement component C9 by recombinant DNA techniques suggests a novel mechanism for its insertion into target membranes.

Authors:  K K Stanley; J Herz
Journal:  EMBO J       Date:  1987-07       Impact factor: 11.598

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.